Nikon to use Lonza know-how to get into gene contract work; Pfizer India plant beset by labor issues;

> Lonza and Nikon have worked a deal for Nikon to use Lonza's expertise and technology to set up its own cell and gene therapy contract manufacturing business. Release

> OPKO Health is getting an FDA- and EMA-approved high-containment research and development, and manufacturing facility in Waterford, Ireland with its acquisition of EirGen. Release

> China's National Health and Family Planning Commission is now requiring detailed records on the supply and storage of vaccines, including the temperatures during their distribution and storage. Story

> Production at a Pfizer ($PFE) plant in Goa, India has reportedly been affected by a labor dispute. aReport

Suggested Articles

Teva will produce its new migraine drug at a plant in Israel and more news of note.

The shortage of childhood cancer drug vincristine was front and center during the Senate hearing for Stephen Hahn, nominee for FDA commissioner.

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.